文献速递胸部肿瘤

国际肺癌研究协会间皮瘤分期项目:第九版胸膜间皮瘤TNM分类中「N」描述符的修订建议

The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the "N" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma.
PubMed 文献 · J Thorac Oncol · 2024-05-09

国际肺癌研究协会基于国际数据库分析胸膜间皮瘤临床与病理N分类,2836例无转移患者纳入分析,中位总生存临床和病理N0均优于N1,单站与多站淋巴结转移无生存差异,建议第九版维持第八版N分类不变。

要点

  • 临床N0中位OS 23.2个月,优于临床N1的18.5个月。
  • 病理N0中位OS 33.8个月,优于病理N1的25.0个月。
  • 单站与多站淋巴结转移总生存无差异,建议第九版N分类不变。

核心结论

  • 临床和病理N分类数据支持第八版所用分类,建议第九版胸膜间皮瘤分期系统不对N分类进行修改。

研究设计与样本

  • 国际肺癌研究协会建立国际数据库,2013年至2022年诊断的7338例胸膜间皮瘤中3598例符合预设分析纳入标准,其中2836例无转移患者纳入本分析。
  • 总生存自诊断日期起计算,患者无论是否接受新辅助治疗均纳入;病理N分析纳入接受切除(胸膜外全肺切除或胸膜切除/剥脱术)的患者。
  • N亚组分析采用Kaplan-Meier法评估总生存。

主要发现

  • 临床N0中位总生存23.2个月,临床N1为18.5个月。
  • 病理N0中位总生存33.8个月,病理N1为25.0个月。
  • 切除后病理N0患者3年总生存率为48%。
  • 单站与多站淋巴结转移的总生存无差异。
  • 切除时采样的淋巴结站数量与总生存差异无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The International Association for the Study of Lung Cancer developed an international database to inform potential revisions in the ninth edition of the TNM classification of diffuse pleural mesothelioma (PM). This study analyzed the clinical and pathologic N categories to determine whether revisions were indicated relative to the eighth edition staging system. METHODS: Of 7338 PM cases diagnosed from 2013 to 2022 and 3598 met all inclusion criteria for planned analyses. Data on 2836 patients without metastases were included in this study. Overall survival (OS) was measured from date of diagnosis. Patients were included regardless of whether they received neoadjuvant treatment. For the pathologic N analysis, patients who underwent resection (extrapleural pneumonectomy or pleurectomy/decortication) were included. N subgroups were analyzed and OS assessed by the Kaplan-Meier method. RESULTS: The existing eighth edition N categories were performed adequately in the ninth edition data set. A median OS advantage was noted for clinical and pathologic N0 versus N1 patients: 23.2 versus 18.5 and 33.8 versus 25.0 months, respectively. Patients with resected pN0 had a 3-year OS of 48%. No difference in OS was noted for single- versus multiple-station nodal metastases. The number of nodal stations sampled at the time of resection was not associated with a difference in OS. CONCLUSIONS: Data regarding clinical and pathologic N categories corroborate those used in the eighth edition. No changes in the N categories are recommended in the ninth edition of PM staging system.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Bille A, Ripley RT, Giroux DJ, et al. The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the "N" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma. J Thorac Oncol. 2024. PMID: 38734073. doi:10.1016/j.jtho.2024.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。